MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine
Clinical trial NCT01397825 · COMPLETED
Trial details
- NCT number
- NCT01397825
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-09
- Primary completion
- 2015-02-05
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.